Stay updated with breaking news from Bio Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Path (NASDAQ:BPTH – Get Free Report) and MannKind (NASDAQ:MNKD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Institutional & Insider Ownership 5.7% of Bio-Path shares are […]
StockNews.com started coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the stock. Bio-Path Stock Up 10.3 % Bio-Path stock opened at $0.55 on Wednesday. The company’s 50-day moving average price is $0.53 and its 200-day moving average price is $0.68. […]
StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the stock. Bio-Path Stock Performance Shares of BPTH stock opened at $0.49 on Wednesday. Bio-Path has a 52-week low of $0.32 and a 52-week high of $2.35. The firm […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 430,900 shares, a decline of 18.6% from the November 30th total of 529,600 shares. Based on an average trading volume of 2,660,000 shares, the days-to-cover ratio […]
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Get Free Report) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 695,700 shares, a decrease of 28.2% from the October 31st total of 969,600 shares. Based on an average daily trading volume, of 2,640,000 shares, the short-interest […]